FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christine Klipping

Research Profile

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Jan Endrikat; Susanne Parke; Marco Serrani; Dietmar Trummer; Ingrid Duijkers; Christine Klipping
Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.
Christine Klipping; Ageeth Remmers; Ingrid J M Duijkers; Thomas Faustmann; Stefan Klein; Christian Zurth; Barbara Schuett
Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women.
Christine Klipping; Joachim Marr; Dietmar Trummer; Ingrid J M Duijkers; Michel P Fortier; Jörg Elliesen
Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christine Klipping (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jan Endrikat; Susanne Parke; Marco Serrani; Dietmar Trummer; Ingrid Duijkers; Christine Klipping
Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.
Contraception 2013;87(2):227-34.
2012: Christine Klipping; Ageeth Remmers; Ingrid J M Duijkers; Thomas Faustmann; Stefan Klein; Christian Zurth; Barbara Schuett
Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women.
Journal of clinical pharmacology 2012;52(11):1704-13.
2012: Christine Klipping; Joachim Marr; Dietmar Trummer; Ingrid J M Duijkers; Michel P Fortier; Jörg Elliesen
Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.
The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists 2012;38(2):84-93.
2012: Christine Klipping; Joachim Marr; Dietmar Trummer; Ingrid J M Duijkers; Michel P Fortier; Jörg Elliesen
Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study.
The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists 2012;38(2):73-83.
2012: Hartmut Blode; Christine Klipping; Frank Richard; Beate Rohde; Dietmar Trummer; Konstanze Diefenbach
Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone.
Contraception 2012;85(2):177-84.
2011: Leena Anttila; Gloria Bachmann; László Hernádi; Michael Kunz; Joachim Marr; Christine Klipping
Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies.
European journal of obstetrics, gynecology, and reproductive biology 2011;155(2):180-2.
2011: Christine Klipping; Uwe Mellinger; Susanne Parke; Marco Serrani; Ingrid Duijkers; Wolfgang Junge
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Drugs in R&D 2011;11(2):159-70.
2010: Ingrid J M Duijkers; Christine Klipping; Paul Grob; Tjeerd Korver
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2010;15(5):314-25.
2010: Ingrid J M Duijkers; Christine Klipping
Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2010;26(3):152-60.
2008: Jan Endrikat; Susanne Parke; Dietmar Trummer; Werner Schmidt; Ingrid Duijkers; Christine Klipping
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Contraception 2008;78(3):218-25.
2008: Christine Klipping; Ingrid Duijkers; Dietmar Trummer; Joachim Marr
Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
Contraception 2008;78(1):16-25.
2008: Majoie Hemelaar; Peter Kenemans; C Erik Hack; Christine Klipping; Marius J van der Mooren
Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Menopause (New York, N.Y.) 2008;15(2):248-55.
2005: Rebeca Massai; L Mäkäräinen; A Kuukankorpi; Christine Klipping; Ingrid J M Duijkers; Thom O M Dieben
The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
Human reproduction (Oxford, England) 2005;20(10):2764-8.
2005: Christine Klipping; Joachim Marr
Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism.
Contraception 2005;71(6):409-16.
2005: Ingrid J M Duijkers; Lonneke Engels; Christine Klipping
Length of the menstrual cycle after discontinuation of oral contraceptives.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2005;20(2):74-9.
2005: Tjeerd Korver; Christine Klipping; Doris Heger-Mahn; Ingrid J M Duijkers; Gonnie van Osta; Thom O M Dieben
Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake.
Contraception 2005;71(1):8-13.
2004: Ingrid J M Duijkers; Leoni A Louwé; D D M Braat; Christine Klipping
One, two or three: how many directions are useful in transvaginal ultrasound measurement of ovarian follicles?
European journal of obstetrics, gynecology, and reproductive biology 2004;117(1):60-3.
2004: Ingrid J M Duijkers; Christine Klipping; Carole H J Verhoeven; Thom O M Dieben
Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Human reproduction (Oxford, England) 2004;19(11):2668-73.
2004: Ingrid J M Duijkers; Carole H J Verhoeven; Thom O M Dieben; Christine Klipping
Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle.
Human reproduction (Oxford, England) 2004;19(11):2674-9.
2004: Doris Heger-Mahn; C Warlimont; T Faustmann; Christoph Gerlinger; Christine Klipping
Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2004;9(3):173-81.
2003: Nelamangala V Nagaraja; Birgit Pechstein; Katharina Erb; Christine Klipping; Robert Hermann; Mathias Locher; Hartmut Derendorf
Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women.
Journal of clinical pharmacology 2003;43(3):243-51.
2002: Ingrid J M Duijkers; Christine Klipping; Peter J Boerrigter; Christel S M Machielsen; Joris J De Bie; Gerrit Voortman
Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.
Human reproduction (Oxford, England) 2002;17(8):1987-93.
2002: Jan Endrikat; Christine Klipping; M Cronin; Christoph Gerlinger; A Ruebig; Werner Schmidt; Bernd Düsterberg
An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.
Contraception 2002;65(3):215-21.
2001: Jan Endrikat; Christine Klipping; Christoph Gerlinger; A Ruebig; Werner Schmidt; T Holler; Bernd Düsterberg
A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, lipids, and carbohydrate metabolism.
Contraception 2001;64(4):235-41.
2001: Katharina Erb; Christine Klipping; Ingrid J M Duijkers; Birgit Pechstein; A Schueler; Robert Hermann
Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.
Fertility and sterility 2001;75(2):316-23.
2000: Nelamangala V Nagaraja; Birgit Pechstein; Katharina Erb; Christine Klipping; Robert Hermann; Georg Niebch; Hartmut Derendorf
Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH-RH antagonist, after subcutaneous administration in healthy premenopausal women.
Clinical pharmacology and therapeutics 2000;68(6):617-25.
2000: Ingrid J M Duijkers; Christine Klipping
Ultrasonographic assessment of endocervix and cervical mucus in ovulatory menstrual cycles.
European journal of obstetrics, gynecology, and reproductive biology 2000;93(1):13-7.
1998: Christine Klipping; Doris Heger-Mahn
Discussion on early clinical drug development in the target population with respect to the field of reproductive endocrinology.
International journal of clinical pharmacology and therapeutics 1998;36(11):591-3.
1998: Ingrid J M Duijkers; Christine Klipping; WN Willemsen; D Krone; E Schneider; Georg Niebch; Robert Hermann
Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers.
Human reproduction (Oxford, England) 1998;13(9):2392-8.
1997: Ingrid J M Duijkers; Christine Klipping; TM Mulders; Henk J Out; Herjan J T Coelingh Bennink; HM Vemer
Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations.
Human reproduction (Oxford, England) 1997;12(11):2379-84.
1997: Robert Hermann; Doris Heger-Mahn; M Mahler; M Seibert-Grafe; Christine Klipping; K Breithaupt-Grögler; C de Mey
Adverse events and discomfort in studies on healthy subjects: the volunteer's perspective. A survey conducted by the German Association for Applied Human Pharmacology.
European journal of clinical pharmacology 1997;53(3-4):207-14.